Sudeep Pharma Ltd. (SUDEEPPHRM): Sudeep Pharma Share Price hits fresh 52-week high at Rs 1,350.90
- September 1, 2026
- Posted by: Harsh Piplani
- Category: News
Sudeep Pharma Share Price touched Rs 1,350.90, up 1.66%, and hit a fresh 52-week high of Rs 1,356.80. The company’s market capitalisation stood at Rs 15,009.18 Cr, placing the move in a large-capitalisation context.
Sudeep Pharma Share Price is in focus after Sudeep Pharma Ltd. (SUDEEPPHRM) touched a fresh 52-week high of Rs 1,356.80 and last traded at Rs 1,350.90, up Rs 22.05 or 1.66% from the previous close. The stock opened at Rs 1,348.05 and moved between Rs 1,321.90 and Rs 1,356.80 during the morning trade. Market capitalisation stood at Rs 15,009.18 Cr. According to latest Univest data, the move confirms a new yearly high, but the figures do not establish a company-specific catalyst. For readers tracking Sudeep Pharma Share Price Today, the key takeaway is straightforward: the stock is trading near its 52-week peak while valuation and sector positioning remain central to Sudeep Pharma Stock News.
Sudeep Pharma Share Price Today: Price Action Analysis
Univest data shows Sudeep Pharma Share Price today is drawing attention because the fresh 52-week high came alongside a market cap above Rs 15,000 Cr and a turnover of Rs 0.31 Cr. The update matters for investors monitoring Sudeep Pharma Share Price Live, Sudeep Pharma Share Price Update and Sudeep Pharma Latest News, especially when a stock is setting a yearly high in the Indian stock market.
| Metric | Value |
|---|---|
| Current Price | Rs 1,350.9 |
| Previous Close | Rs 1,328.85 |
| Today's Move | +Rs 22.05 (+1.66%) |
| Open | Rs 1,348.05 |
| High | Rs 1,356.8 |
| Low | Rs 1,321.9 |
| Turnover | Rs 0.31 crore |
| Market Capitalisation | Rs 15,009.18 crore |
Sudeep Pharma Ltd. (SUDEEPPHRM) traded at Rs 1,350.9 versus the previous close of Rs 1,328.85, a rise of 1.66%. The stock opened at Rs 1,348.05, reached a high of Rs 1,356.8 and touched a low of Rs 1,321.9.
Sudeep Pharma Share Price Today reflects a session where the stock moved above the previous close of Rs 1,328.85 and reached Rs 1,356.80, which was also its fresh 52-week high. The day change of Rs 22.05 and the 1.66% rise are precise facts from the latest Univest figures. The opening price of Rs 1,348.05 was close to the upper end of the day’s range, while the lowest point was Rs 1,321.90. Turnover stood at Rs 0.31 Cr, which helps quantify traded value without implying anything beyond the recorded market activity. For Sudeep Pharma Share Price News, the most important point is that the stock has moved to a one-year high during the current trading window.
The breakout above the earlier 52-week high is visible from the day’s high of Rs 1,356.80 against the prior peak of Rs 1,356.80, which indicates the stock matched that level during trade. For readers searching Sudeep Pharma Share Price Today, this is the latest factual price event and the central trigger for today’s stock news coverage on Univest.
Sudeep Pharma Ltd. (SUDEEPPHRM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 15,009.18 crore |
| P/E Ratio | 82.18x |
| P/B Ratio | 16.25x |
| ROE | 25.37% |
| ROCE | 28.5% |
| EPS | Rs 16.17 |
| Book Value Per Share | Rs 81.8 |
| Dividend Yield | 0.11% |
Sudeep Pharma Ltd. (SUDEEPPHRM) fundamental metrics show P/E 82.18x, P/B 16.25x, ROE 25.37%, ROCE 28.5%. These figures provide context only and are not a buy or sell signal.
Sudeep Pharma Ltd. has a market capitalisation of Rs 15009.18 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 82.18x, P/B at 16.25x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 25.37% and ROCE of 28.5%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 16.17, book value per share of Rs 81.8, dividend yield of 0.11%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.47x, median ROE of 11.78%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 82.18x |
| Benchmark Median P/E | 32.47x |
| Benchmark Average P/E | 48.59x |
| Benchmark P/E Range | 3.2x to 659.73x |
| Company P/B Ratio | 16.25x |
| Benchmark Median P/B | 2.89x |
| Company ROE | 25.37% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 28.5% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 15,009.18 crore |
| Benchmark Median Market Cap | Rs 673.68 crore |
Sudeep Pharma Ltd. (SUDEEPPHRM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Sudeep Pharma Ltd. (SUDEEPPHRM) has a P/E ratio of 82.18x, which is above the benchmark median of 32.47x, a difference of +153.1%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Sudeep Pharma Ltd. (SUDEEPPHRM) has a ROE of 25.37%, which is above the benchmark median of 11.78%, a difference of +115.37%. Sudeep Pharma Ltd. (SUDEEPPHRM) has a ROCE of 28.5%, which is above the benchmark median of 13.63%, a difference of +109.1%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Natco Pharma Ltd. | NATCOPHARM | 14,848.21 | 12.98 | 1.59 | 16.3 | 17.16 |
| Concord Biotech Ltd. | CONCORDBIO | 14,800.58 | 53.75 | 7.14 | 13.54 | 18.04 |
| Marksans Pharma Ltd. | MARKSANS | 14,793.53 | 28.63 | 4.65 | 15.31 | 21.1 |
| Jubilant Pharmova Ltd. | JUBLPHARMA | 14,713.6 | 41.79 | 2.06 | 5.97 | 8.69 |
| Alembic Pharmaceuticals Ltd. | APLLTD | 15,878.37 | 22.9 | 2.72 | 12.35 | 11.74 |
Sudeep Pharma Ltd. (SUDEEPPHRM) has a P/E ratio of 82.18x compared with the displayed peer median of 28.63x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 25.37% compares with a peer median of 13.54% across the companies shown in the table. ROCE stood at 28.5% versus the displayed peer median of 17.16%, providing a capital-efficiency comparison. Sudeep Pharma Ltd. (SUDEEPPHRM) has a market capitalisation of Rs 15,009.18 crore. Among the 5 peers shown, 1 has a larger market capitalisation.
Why Investors Are Watching Sudeep Pharma
- Sudeep Pharma Share Price touched a fresh 52-week high of Rs 1,356.80 during the current trade.
- The stock last traded at Rs 1,350.90, up 1.66% from the previous close of Rs 1,328.85.
- Market capitalisation stood at Rs 15,009.18 Cr.
- P/E was 82.18 and P/B was 16.25, both above the same-industry medians.
- ROE of 25.37% and ROCE of 28.5% were above the industry medians.
About Sudeep Pharma
Sudeep Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. In Univest stock coverage, the company is tracked through its market cap, valuation ratios, return ratios and price performance. For Sudeep Pharma Share Price readers, that means the focus stays on the verified financial profile and the current 52-week high event. Sudeep Pharma Stock News today is therefore shaped by the company’s listed-market data, sector benchmark and peer comparisons rather than by unverified commentary.
Frequently Asked Questions
Why is Sudeep Pharma Share Price in focus today?
Ans. Sudeep Pharma Share Price is in focus because it touched a fresh 52-week high of Rs 1,356.80 and last traded at Rs 1,350.90, up 1.66% from the previous close of Rs 1,328.85.
What is the current Sudeep Pharma Share Price?
Ans. The current Sudeep Pharma Share Price was Rs 1,350.90 at the latest update. The stock also opened at Rs 1,348.05 and moved within a day range of Rs 1,321.90 to Rs 1,356.80.
Did Sudeep Pharma hit a 52-week high?
Ans. Yes. Sudeep Pharma Share Price touched Rs 1,356.80, which is the fresh 52-week high in today’s trade. That makes the yearly high the main price event in Sudeep Pharma Stock News.
What is the market capitalisation of Sudeep Pharma?
Ans. Sudeep Pharma’s market capitalisation stood at Rs 15,009.18 Cr. That places Sudeep Pharma Share Price in a company with a market value above the same-industry median in the Healthcare benchmark.
How expensive is Sudeep Pharma compared with peers?
Ans. Sudeep Pharma Share Price is backed by a P/E of 82.18 and a P/B of 16.25, both above the same-industry medians. Its ROE and ROCE are also above the benchmark medians.
What do Sudeep Pharma’s EPS and book value show?
Ans. Sudeep Pharma’s EPS is Rs 16.17 and book value is Rs 81.8. EPS shows earnings per share, while book value indicates the accounting net worth behind each share of Sudeep Pharma Share Price.
What is Sudeep Pharma’s dividend yield?
Ans. Sudeep Pharma’s dividend yield is 0.11%. It is a historical yield measure relative to the current Sudeep Pharma Share Price and should be read alongside valuation and return ratios.
Which sector and industry does Sudeep Pharma belong to?
Ans. Sudeep Pharma belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That context is important for Sudeep Pharma Share Price because the company is being compared with 203 same-industry companies.
Track Sudeep Pharma Share Price on Univest
Use Sudeep Pharma Ltd. (SUDEEPPHRM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Sudeep Pharma Share Price on Univest for live price updates, 52-week levels, key valuation ratios, return ratios, market capitalisation, sector context and peer comparison. Univest also helps readers follow Sudeep Pharma Share Price Today and related Sudeep Pharma Latest News in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
